1. Home
  2. PBYI vs QIPT Comparison

PBYI vs QIPT Comparison

Compare PBYI & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • QIPT
  • Stock Information
  • Founded
  • PBYI 2010
  • QIPT 1993
  • Country
  • PBYI United States
  • QIPT United States
  • Employees
  • PBYI N/A
  • QIPT N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • QIPT
  • Sector
  • PBYI Health Care
  • QIPT
  • Exchange
  • PBYI Nasdaq
  • QIPT Nasdaq
  • Market Cap
  • PBYI 176.1M
  • QIPT 118.5M
  • IPO Year
  • PBYI N/A
  • QIPT N/A
  • Fundamental
  • Price
  • PBYI $2.59
  • QIPT $2.84
  • Analyst Decision
  • PBYI Strong Buy
  • QIPT Strong Buy
  • Analyst Count
  • PBYI 1
  • QIPT 3
  • Target Price
  • PBYI $7.00
  • QIPT $7.67
  • AVG Volume (30 Days)
  • PBYI 345.1K
  • QIPT 267.3K
  • Earning Date
  • PBYI 10-31-2024
  • QIPT 08-14-2024
  • Dividend Yield
  • PBYI N/A
  • QIPT N/A
  • EPS Growth
  • PBYI N/A
  • QIPT N/A
  • EPS
  • PBYI 0.18
  • QIPT N/A
  • Revenue
  • PBYI $219,143,000.00
  • QIPT $244,231,000.00
  • Revenue This Year
  • PBYI N/A
  • QIPT $25.19
  • Revenue Next Year
  • PBYI N/A
  • QIPT $6.04
  • P/E Ratio
  • PBYI $13.90
  • QIPT N/A
  • Revenue Growth
  • PBYI N/A
  • QIPT 29.31
  • 52 Week Low
  • PBYI $2.13
  • QIPT $2.60
  • 52 Week High
  • PBYI $7.73
  • QIPT $5.88
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 45.60
  • QIPT 44.52
  • Support Level
  • PBYI $2.23
  • QIPT $2.68
  • Resistance Level
  • PBYI $2.42
  • QIPT $2.90
  • Average True Range (ATR)
  • PBYI 0.15
  • QIPT 0.10
  • MACD
  • PBYI 0.05
  • QIPT 0.02
  • Stochastic Oscillator
  • PBYI 76.60
  • QIPT 52.94

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About QIPT Quipt Home Medical Corp.

Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.

Share on Social Networks: